FMR CORP 13D/13G Filings for Intersect ENT, Inc. (XENT)

FMR CORP 13D and 13G filings for Intersect ENT, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-09-10
09:33 am
Sale		 2021-09-09 13G Intersect ENT, Inc.
XENT		 FMR CORP 0
0.000%		 -3,495,000decrease
(Position Closed)		 Filing
2021-06-10
11:37 am
Purchase		 2021-06-09 13G Intersect ENT, Inc.
XENT		 FMR CORP 3,495,000
10.545%		 535,000increase
(+18.07%)		 Filing
2021-02-08
10:25 am
Purchase		 2021-02-05 13G Intersect ENT, Inc.
XENT		 FMR CORP 2,960,000
9.046%		 2,960,000increase
(New Position)		 Filing